Learn how International Reference Pricing (IRP) shapes generic drug costs globally. Discover the mechanics of internal vs. external pricing, real-world impacts on shortages and savings, and future trends in pharmaceutical policy.
Americans pay less for generic drugs than Europeans due to fierce competition and PBM discounts, while paying far more for brand-name drugs that fund global innovation. Here's why the systems differ-and what it means for patients.